Citation Impact
Citing Papers
Regulatory T cells in autoimmune kidney diseases and transplantation
2023 StandoutNobel
Graft microvascular disease in solid organ transplantation
2014 StandoutNobel
A bridge too far: We have not overstepped the line for extended deceased donors
2014
Toward an Optimized Process for Clinical Manufacturing of CAR-Treg Cell Therapy
2020
Extrahepatic Manifestations of Nonalcoholic Fatty Liver Disease
2016
Pathogenesis of Hepatorenal Syndrome: Implications for Therapy
2015
Preexisting Donor-Specific HLA Antibodies Predict Outcome in Kidney Transplantation
2010 Standout
Complement-Binding Anti-HLA Antibodies and Kidney-Allograft Survival
2013 Standout
Next-generation regulatory T cell therapy
2019
Applicability and Results of Maastricht Type 2 Donation After Cardiac Death Liver Transplantation
2011
Non-alcoholic fatty liver disease and liver transplantation
2016
Glomerular filtration rate equations for liver-kidney transplantation in patients with cirrhosis: Validation of current recommendations
2013
Past, Present, and Future of Regulatory T Cell Therapy in Transplantation and Autoimmunity
2019
Granzymes and perforin in solid organ transplant rejection
2009
Kidney biomarkers in cirrhosis
2016
Does Donation After Cardiac Death Utilization Adversely Affect Hepatocellular Cancer Survival?
2016
New Treg cell-based therapies of autoimmune diseases: towards antigen-specific immune suppression
2020 StandoutNobel
Kidney biomarkers and differential diagnosis of patients with cirrhosis and acute kidney injury
2013
Opportunities for Treg cell therapy for the treatment of human disease
2023 StandoutNobel
AASLD Practice Guidance on the clinical assessment and management of nonalcoholic fatty liver disease
2023 Standout
Guidelines on the Use of Therapeutic Apheresis in Clinical Practice – Evidence‐Based Approach from the Writing Committee of the American Society for Apheresis: The Eighth Special Issue
2019 Standout
Taking regulatory T cells into medicine
2021 StandoutNobel
Regulatory T Cells and Human Disease
2020 StandoutNobel
Donor characteristics and risk of hepatocellular carcinoma recurrence after liver transplantation
2015
Special Issue: KDIGO Clinical Practice Guideline for the Care of Kidney Transplant Recipients
2009 Standout
2014 ACC/AHA/AATS/PCNA/SCAI/STS Focused Update of the Guideline for the Diagnosis and Management of Patients With Stable Ischemic Heart Disease
2014
Target of rapamycin inhibitors (TOR-I; sirolimus and everolimus) for primary immunosuppression in kidney transplant recipients
2006
The diagnosis and management of nonalcoholic fatty liver disease: Practice guidance from the American Association for the Study of Liver Diseases
2017 Standout
Guidelines for Adult Stroke Rehabilitation and Recovery
2016 Standout
2014 ACC/AHA/AATS/PCNA/SCAI/STS Focused Update of the Guideline for the Diagnosis and Management of Patients With Stable Ischemic Heart Disease
2014
Part 8: Post–Cardiac Arrest Care
2015 Standout
Coronary artery disease in decompensated patients undergoing liver transplantation evaluation
2018
EASL Clinical Practice Guidelines: Management of hepatocellular carcinoma
2018 Standout
2014 AHA/ACC Guideline for the Management of Patients With Non–ST-Elevation Acute Coronary Syndromes
2014 Standout
EASL Clinical Practice Guidelines for the management of patients with decompensated cirrhosis
2018 Standout
Immunology of Acute and Chronic Wound Healing
2021 Standout
Works of Anton Skaro being referenced
Perception Versus Reality?: Virtual Crossmatch—How to Overcome Some of the Technical and Logistic Limitations
2009
A Phase I Clinical Trial with Ex Vivo Expanded Recipient Regulatory T cells in Living Donor Kidney Transplants
2018
Factors Associated With Major Adverse Cardiovascular Events After Liver Transplantation Among a National Sample
2016
Long-Term Kidney Allograft Function and Survival in Prednisone-Free Regimens
2012
The impact of ischemic cholangiopathy in liver transplantation using donors after cardiac death: The untold story
2009
The impact of coronary artery disease on outcomes after liver transplantation
2015
Cardiovascular Risk Assessment of the Liver Transplant Candidate
2011
CD8 T cells mediate aortic allograft vasculopathy by direct killing and an interferon-?-dependent indirect pathway
2004
Outcomes and Native Renal Recovery Following Simultaneous Liver–Kidney Transplantation
2012
Ischemic Cholangiopathy After Controlled Donation After Cardiac Death Liver Transplantation
2011
A comprehensive risk assessment of mortality following donation after cardiac death liver transplant – An analysis of the national registry
2011
Comparative effectiveness of donation after cardiac death versus donation after brain death liver transplantation: Recognizing who can benefit
2012
Impact of renal impairment on cardiovascular disease mortality after liver transplantation for nonalcoholic steatohepatitis cirrhosis
2015
The Increased Costs of Donation After Cardiac Death Liver Transplantation
2010